Erratum: Simplified NaCl based 68Ga concentration and labeling procedure for rapid synthesis of 68Ga radiopharmaceuticals in high radiochemical purity(Bioconjugate Chemistry (2012) 23:8 (1712-1717) DOI: 10.1021/bc300103t);Simplified NaCl based 68Ga concentration and labeling procedure for rapid synthesis of 68Ga radiopharmaceuticals in high radiochemical purity

Bioconjugate Chemistry

Volumn 23, Issue 8, 2012, Pages 1712-1717

  Mueller, Dirk ^a   Klette, Ingo ^a   Baum, Richard P ^a   Gottschaldt, M ^b   Schultz, Michael K ^c   Breeman, Wouter A P ^d  

^a ZENTRALKLINIK BAD BERKA   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^c UNIVERSITY OF IOWA   (United States)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAS CHROMATOGRAPHY; PEPTIDES; PHASE SEPARATION; POSITIVE IONS; PROJECTILES; QUALITY CONTROL;

BIOCONJUGATES; CATION EXCHANGE CARTRIDGE; CONCENTRATION METHOD; HIGHER EFFICIENCY; LABELING METHODS; LABELING PROCEDURES; RADIOCHEMICAL PURITY; RADIOCHEMICAL YIELD; RAPID SYNTHESIS; SIMPLE++;

SODIUM CHLORIDE;

AMMONIUM ACETATE; GALLIUM 68; OCTREOTIDE; PEPTIDE; RADIOPHARMACEUTICAL AGENT; SODIUM CHLORIDE; TETRAXETAN; TETRAXETAN OCTREOTATE; TETRAXETAN PHENYL TYROSYL OCTREOTIDE; UNCLASSIFIED DRUG;

ARTICLE; CATION EXCHANGE; CONCENTRATION (PARAMETERS); CONJUGATION; GAS CHROMATOGRAPHY; ISOTOPE LABELING; PURIFICATION; QUALITY CONTROL; RADIOCHEMISTRY; SOLID PHASE EXTRACTION; SYNTHESIS;

EID: 84865113848     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc400437p     Document Type: Erratum

References (16)

1. Prasad, V. and Baum, R. P. (2010) Biodistribution of the Ga-68 labeled somatostatin analogue DOTA-NOC in patients with neuroendocrine tumors: characterization of uptake in normal organs and tumor lesions Q. J. Nucl. Med. Mol. Imaging 54, 61-67
2. 68Ga-labeled affibody molecules J. Nucl. Med. 51, 892-897
3. Sainz-Esteban, A., Prasad, V., and Baum, R. P. (2010) Interesting image. Pancreatic neuroendocrine tumor with involvement of the inferior mesenteric vein diagnosed by Ga-68 DOTA-TATE PET/CT Clin. Nucl. Med. 35, 40-41
4. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals Contr. Media Mol. Imaging 3, 67-77
5. Ballinger, J. R. and Solanki, K. K. (2011) What will be required to bring (68)Ga-labelled peptides into routine clinical use? Nucl. Med. Commun. 32, 1109-1112
6. Tolmachev, V., Altai, M., Sandström, M., Perols, A., Eriksson Karlström, A. H., Boschetti, F., and Orlova, A. (2011) Evaluation of a maleimido derivative of NOTA for site-specific labeling of Affibody molecules Bioconjugate Chem. 22, 894-902
7. 68Ga-bisphosphonates: first human study Eur. J. Nucl. Med. Mol. Imaging 37, 834
8. 68Ga: practical aspects of radiolabelling Contr. Media Mol. Imaging 6, 492-498
9. 68Ga labelled sugar derivative Eur. J. Inorg. Chem. 4298-4307
10. 68Ga-labelled DOTA-derivatised peptide ligands Eur. J. Nucl. Med. Mol. Imaging 31, 1097-1104 (Pubitemid 39050176)
11. Müller, D., Klette, I., Wortmann, R., and Baum, R. P. (2006) Markierung von DOTA-Peptiden mit Gallium-68 für die nuklearmedizinische Routinediagnostik Nuklearmedizin 45, A 88-89
12. Mueller, D., Klette, I., Gottschaldt, M., and Baum, R. P. (2009) Radiolabeling of fragile macroligands with Ga-68 J. Labeled Compd. Radiopharm. 52, S477
13. 68Ga generator and aspects of radiolabelling DOTA-peptides Appl. Radiat. Isot. 69, 308-315
14. 68Ga for medical application J. Nucl. Med. 48, 1741-1748 (Pubitemid 47572722)
15. 68Ga generator eluate for the labeling of fragile peptides World J. Nucl. Med. 10, 77-78
16. 68Ga Eur. J. Nucl. Med. Mol. Imaging 32, 478-485 (Pubitemid 40591180)